Gonna have a hard time holding over 1.60 as warrants are exercised above that. Every time it gets over, it's eventually pushed back down.
Ask him when they are going to finally come out with some meaty news that justifies all of the $ raises and reminds us all why we are invested in the company. So far, the news we've been receiving has not generated that much excitement and the share price has been languishing. I'd love to see true validation of the future prospects of the company. I'm tired of seeing the share price go on runs based on nothing, only to see it fall back down while every Tom, #$%$ and Harry calls out "this is the bottom".
Not sure why my post got thumbs down. Look up how the share price reacts in the past after every conference. Investors always expect big things from companies at conferences and big things are never, ever delivered. These conferences are always general company and clinical trial overviews. It's not just isolated to AMBS.
Anyone who expects price jumps from conferences has obviously not been investing in pharma/bio for very long.
They never present anything at conferences so don't expect anything at this one.
It's the smart way to do it, rather than kill the momentum after results are positive. 2014 is going to be great.
News is out during trading hours. Don't see that very often...
Now that financing is addressed this should continue it's run up even harder now... i would think.
lmao, sure... Coming from someone who cannot spell "bought". I'll take my pumps from a competent speller, thank you.
Just today Jason Napodano said he too has no idea what is going on with the AMBS price per share and that it's a highly manipulated stock. I'm waiting to see if we see the .03s, which I think is realistic if we don't get any concrete news soon.
I'll be adding large when it gets down to low .03s. If it doesn't, no big deal, I already have a large enough position. Hoping to see retirement in 5 years off this stock.
I'm assuming it jumped 4x based on news though, correct? This is not going to jump without news, and it's sounding like we aren't going to get any until next year.
Or it can continue to bleed down to .03s and base there, which is the most likely scenario if we do not get any news that will move the needle the other way.
The chart is looking the exact same as it did the last time it made it's final drop into the .03s, where it based for months.
I rode this out during the last downtrend that lasted month, and months (it felt like it was close to a year) and this feels like the exact same thing is happening. A 5% bleed every single day and we'll soon be in low .03s and may even dip into .02s like last time. Frustrating, and I didn't think we'd see the share price this low again, but unless Gerald releases anything of substance, this is where we are heading.
Knew I should have sold on that last pop into .08s.
AMBS outlines its plans and updates the market place more than 99% of nationally listed bio companies. It's the most transparent bio company that I'm invested in.
I don't think I've ever seen any scare tactics posted here by CC and I was under the impression he is long AMBS.
Irregardless, we're all big boys and girls here and if you're making your investment decisions based off a message board, you're most likely going to lose your money.
It's not that bad... yet. I remember how good the INO board was when it was .50 and few people knew about it. Now everyone is an INO investment pro. lmao.
There used to be intelligent posts, and there still are, so don't get me wrong. But for every intelligent post, there are two or three posts that range from absurd dot connecting and speculation to accusation and name calling.
We're all here for the same reason, so attacking each other does nothing. Nor does heavy pumping or speculation. You know what's going on about as much as every other poster here, which is nothing. We're all in the dark here, so why not just sit back and wait to react and talk about news when events develop.
I just don't want to see this turn into a typical YMB – completely useless.